[Tolerability of a new non-ionic contrast medium, iopromide in x-ray computed tomography. Comparison with ioxaglate 320 mgI/ml].
Three randomized prospective and comparative trials were conducted in 165 patients undergoing brain (80) and whole body (85) CT scans. The two products compared where a new non-ionic contrast medium iopromide 300 (brain) and 370 (whole body) and the ionic low osmolar contrast medium, ioxaglate 320. Imaging quality was not different but the tolerance of the non-ionic medium was significantly better (p less than 0.05).